Teladoc Stock Gains As Amazon Partnership Fuels Push for Consumer-Centric Healthcare
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 14 2025
0mins
Source: Benzinga
Partnership with Amazon: Teladoc Health has partnered with Amazon to enhance access to its chronic condition management programs, allowing eligible Amazon customers to enroll in services for diabetes, hypertension, pre-diabetes, and weight management.
Stock Performance and Predictions: Teladoc's shares have risen by 7.94% in premarket trading, with analysts using technical analysis to predict future stock performance based on moving averages and trends, indicating a generally bullish outlook if the stock remains above its 200-day moving average of $10.07.
Analyst Views on BUYO
Wall Street analysts forecast BUYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUYO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 29.615
Low
Averages
High
Current: 29.615
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
